Aims/Introduction: Vitamin D 3 deficiency can lead to male hypogonadism in diabetes mellitus, but the target organs and the mechanism driving the disorder are unclear. This experiment was designed to study the relationship between vitamin D 3 deficiency and hypogonadism in diabetes mellitus. Materials and Methods: Rats with streptozotocin-induced diabetes were randomly divided into four groups and treated with different doses of vitamin D 3 : blank (no vitamin D 3 ), low (0.025 lg/kg/day), high (0.1 lg/kg/day), high (0.1 lg/kg/day) and with bisphenol A diglycidyl ether (peroxisome proliferator-activated receptor gamma inhibitor 30 mg/kg/ day). They were compared with wild-type rats. Results: After 12 weeks, the vitamin D 3 supplements had partially restored testicular pathological changes, as shown by reduced testicular fibrosis related to downregulation transforming growth factor beta 1 and apoptosis related to downregulation of nuclear factor kappa B, but not the pituitary gland. The expression of peroxisome proliferator-activated receptor gamma, which can inhibit transforming growth factor beta 1 and nuclear factor kappa B, was significantly increased after treatment with vitamin D 3 . Conclusions: These results suggest that treatment with vitamin D 3 can improve testicular function in diabetic rats through the peroxisome proliferator-activated receptor gamma/transforming growth factor beta 1/nuclear factor kappa B signaling pathway.
INTRODUCTION
Diabetes mellitus is a multisystemic syndrome. In recent years, male hypogonadism caused by diabetes mellitus has begun to attract attention 1, 2 . Multiple metabolic disorders caused by diabetes mellitus are related to the deterioration of gonad function, including the disorder of glucose metabolism caused by insulin secretion defects; in addition, insulin resistance leads to testosterone synthesis disorder 1, 3 and hyperglycemia-induced testicular and epididymal microvascular disease, which limit the ability of the testes to produce sperm and cause epididymis recession 4, 5 .
The active form of vitamin D 3 , 1a, 25-dihydroxy vitamin D 3 (1,25- [OH] 2 D 3 ), exerts its effects through the vitamin D receptor (VDR) 6 . In the classical pathway, vitamin D 3 binds to its nuclear receptor to regulate calcium and phosphorus metabolism. Recent studies have found that vitamin D 3 can affect a variety of disease processes, including diabetes, prediabetes and autoimmune conditions, through more than one pathway [7] [8] [9] . With the discovery of the expression of the VDR in the central and peripheral reproductive systems, researchers have realized that vitamin D 3 might have an impact on the gonadal axis and play a role in hypogonadism in diabetes mellitus 8, 10 . Therefore, we studied the relationship between vitamin D 3 and diabetes mellitus-driven hypogonadism. A previous study from our group showed that vitamin D 3 supplement or treatment can partially improve testicular function in men with diabetes mellitus 11 . However, many questions remain. It is not clear if vitamin D 3 deficiency affects the central reproductive organs or gonads; the pathway through which vitamin D 3 acts in this disease state is also unknown.
Peroxisome proliferator-activated receptor gamma (PPAR-c) is an important component of the nuclear receptor superfamily. In addition, the activation of PPAR-c signaling can improve testicular function 12 , and vitamin D 3 can regulate the expression of PPAR-c 13 . Therefore, we speculated that vitamin D 3 , the PPAR-c pathway and testicular function could be linked. In the present study, we investigated whether the central reproductive organs or gonads were affected by vitamin D 3 supplementation, and studied the pathway that regulates its biological effects, with the aim of improving clinical diagnosis and treatment.
METHODS

Materials
Streptozotocin (STZ) was purchased from Sigma-Aldrich (St. Louis, Missouri, USA). The following rabbit anti-rat polyclonal antibodies were used: anti-VDR (Abcam, Cambridge, Massachusetts, USA), anti-PPAR-c (Santa Cruz Biotechnology, Santa Cruz, California, USA), anti-transforming growth factor beta 1 (TGF-b1), anti-nuclear factor kappa B (NF-jB), antiphospho-NF-jB, anti-B-cell lymphoma 2 (Bioworld Technology, St. Louis Park, Minnesota, USA), anti-Bcl-2-associated X protein (Bax), anti-inhibitor of NF-jB alpha and anti-b-actin (Sangon Biotech, Shanghai, China).
Animals and treatment
Specific-pathogen-free, 8-week-old male Sprague-Dawley rats (200 -20 g) were purchased from the Experimental Animal Center of Henan Province, China. All animal studies were approved by the Animal Care and Use Committee of the First Affiliated Hospital of Zhengzhou University, and fully complied with the university guidelines for the care and use of laboratory animals.
After 12 h of fasting, 25 rats were injected once, intraperitoneally, with a solution of 60 mg STZ/kg to induce diabetes. Their blood glucose (BG) levels were measured to validate the induction of diabetes (BG > 16.7 mmol/L) 72 h after STZ injection. Five rats that received an injection of diluent buffer alone served as the normal control group (NC group). The diabetic rats were randomly divided into four groups of six rats each: untreated diabetic rats, rats treated with a low dose of active vitamin D 3 (LVD; 0.025 lg/kg/day), rats treated with a high dose of active vitamin D 3 (HVD; 0.1 lg/kg/day), and rats treated with a high dose of active vitamin D 3 (0.1 lg/kg/day) and the PPAR-c inhibitor bisphenol A diglycidyl ether (BADGE; 30 mg/kg/day; Sigma-Aldrich). The vitamin D 3 and BADGE doses were determined by consulting the literature and previous experiments 11, 14 . During the following 12 weeks, each vitamin D 3 group received 1,25-(OH) 2 D 3 dissolved in 0.1 mL peanut oil daily, at the doses described above, by oral gavage. The BADGE group received a daily intraperitoneal injection of BADGE (30 mg/kg) in 10% dimethyl sulfoxide in phosphatebuffered saline. The remaining groups received intraperitoneal injections of the same dilution of dimethyl sulfoxide in phosphate-buffered saline. The NC and diabetic groups received daily 0.1 mL peanut oil blanks.
Tissue collection
At the end of 12 weeks, after weighing the rats and testing their BG levels, the rats were anesthetized with chloral hydrate and blood samples were collected from them to test serum electrolyte and hormone levels. Finally, the rats were killed by decapitation. The testes and pituitary were dissected for use in biochemical studies. The testes were weighed after removal from the rats. Some of the tissues were stored in liquid nitrogen for real-time polymerase chain reaction (PCR) and western blotting analysis, and others were fixed in 10% buffered formalin or 4% buffered glutaraldehyde for histological assessments by light microscopy or electron microscopy, respectively.
Sperm count and proportion of deformed sperm
The right epididymis of each animal was minced, dipped in 4 mL phosphate-buffered saline, and then incubated in a water bath at 37°C for 10 min. A total of 10 lL of the sperm suspension was dropped on dry SpermBlue slides (MICROPTIC, Barcelona, Spain), and the slides were heated for 15 s. Then, the total number of sperm and that of deformed sperm were calculated using a hemocytometer under a light microscope.
Light and transmission electron microscopy
The pathology of the testes and pituitaries in hematoxylineosin, Masson trichome (JianCheng Bioengineering Institute, Nanjing, China) and terminal deoxynucleotidyl transferase dUTP nick-end labeling (Roche, Basel, Switzerland) stained sections was examined by light microscopy. The testes and pituitary glands were dissected into small cubes (1 mm 3 ), fixed in 4% pre-cooling glutaraldehyde and then fixed using osmium acid, dehydrated with an acetone gradient, soaked in epoxy resin, embedded, sliced, and stained with uranium acetate and citric acid lead.
The ultrastructure of the testes and pituitary glands was examined with an H-7500 transmission electron microscope (Hitachi, Tokyo, Japan).
Enzyme-linked immunosorbent assay Serum was separated from blood by centrifugation at 3000 g for 5 min at 4°C, supernatants were collected, and levels of 1,25-(OH) 2 D 3 , testosterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), insulin and C-peptide were measured using enzyme-linked immunosorbent assay kits (AMEKO, Shanghai, China), according to the manufacturer's instructions, in three duplicate wells. The optical density of each well was measured with a microplate reader. The standard curve was prepared using GraphPad 5 software (GraphPad Software Inc., La Jolla, California, USA), and the concentrations of the hormones were then calculated.
Ribonucleic acid extraction and quantitative reverse transcription polymerase chain reaction Total ribonucleic acid (RNA) was extracted from the testes with TRIzol TM (TaKaRa Bio, Shiga, Japan). Complementary deoxyribonucleic acid was synthesized with the M-MuLV First-Strand cDNA Synthesis Kit (Sangon Biotech). The expression of the target genes was assessed using SGExcel UltraSYBR Mixture Kit (Sangon Biotech) on the Applied Biosystems â 7500 FAST System (Foster City, California, USA). The relative target gene expression was normalized to the expression of rat b-actin. The 2 ÀDDC t method was used to calculate the values. The primers were obtained from Sangon Biotech, and the primer details are available on request (Table 1) .
Protein extraction and western blotting
Total protein was extracted from the testes with a protein extraction reagent (CWBio, Beijing, China). Western blotting was carried out, as previously described 11 . The membranes were exposed to anti-VDR (1:100), anti-PPAR-c (1:100), anti-TGF-b1 (1:500), anti-NF-jB (1:500), anti-phospho-NF-jB (1:500), anti-B-cell lymphoma 2 (1:500), anti-Bax (1:1,000), anti-inhibitor of NF-jB alpha (1:500) and anti-b-actin (1:1,000). After incubation with the horseradish peroxidaseconjugated secondary antibody, the membranes were treated with enhanced chemiluminescence substrate (Life Technologies, Carlsbad, California, USA) and exposed to X-ray film. The relative optical density of each target protein was determined and normalized to b-actin levels using ImageJ software (public domain; National Institutes of Health, Bethesda, Maryland, USA).
Immunofluorescence and immunohistochemistry
Immunofluorescent and immunohistochemical staining was carried out as previously described 11, 15, 16 . Primary antibodies against VDR (1:1,000), anti-PPAR-c (1:50), anti-TGF-b1 (1:50), FSH (1:10) and LH (1:10) were used. The distributions and localizations of the target proteins were visualized by light and fluorescence microscopy. Immunofluorescence and immunohistochemical signals were quantified with ImageJ (National Institutes of Health).
Statistical analysis
The data were analyzed with SPSS 21.0 software (IBM, Armonk, New York, USA). Statistical differences between the experimental groups were determined by one-way analysis of variance, followed by the Bonferroni test for comparisons. Results are expressed as mean -standard deviation, and P < 0.05 is the standard used for statistical significance.
RESULTS
General conditions of the animals
Unlike those in the NC group, the rats in the diabetic group showed symptoms such as polyuria, polydipsia and polyphagia. Differences can also be seen in their BG levels and bodyweights. The BG levels were significantly higher and the bodyweights were significantly lower in the diabetic groups than in the NC group (P < 0.05). However, there were no observed significant differences in the BG levels or bodyweights among the diabetic, LVD, HVD and BADGE groups (P > 0.05). The serum levels of calcium in the diabetic groups were lower than in the NC group, although the differences were not statistically significant (P > 0.05). The levels of phosphate were not statistically different among the groups (P > 0.05; Table 2 ).
Effects of vitamin D 3 on hormones
Compared with the NC group, the serum level of vitamin D 3 in the diabetic group was lower (P < 0.05; Figure 1a ), but could be increased by vitamin D 3 treatment. Similarly, the level of testosterone was lower (P < 0.05; Figure 1b ) in the diabetic group, and higher in the LVD and HVD groups than in the NC group; on treatment with BADGE, the level of testosterone decreased to the level in the diabetic group.
As FSH and LH are important for the regulation of gonadal function, which can reflect the condition of the central reproductive organs, we tested the effects of vitamin D 3 on their serum levels. We found that the levels of FSH and LH did not statistically differ among the groups (P > 0.05; Figure 1c,d ). This result suggests that diabetes might have no effect on pituitary function.
In order to clarify the effect of vitamin D 3 on pancreas function, we measured the insulin and C-peptide levels in the experimental animals. We found that, compared with the levels in the NC group, the serum levels of insulin and C-peptide in the diabetic, LVD, HVD and BADGE groups were lower; however, we did not observe a statistical difference in the levels Spermatogenesis in diabetic rats improved after vitamin D 3 treatment Spermatogenesis by the testis is an important index to evaluate the gonad function of male rats. We observed that, compared with the counts in the NC group, the sperm counts were significantly lower in the diabetic group (P < 0.05; Figure 2a,b) , and the proportion of deformed sperm was significantly higher (P < 0.05; Figure 2c ). After treatment with vitamin D 3 , the total counts and activity of sperm were higher and the proportion of deformed sperm was lower in the LVD and HVD groups than in the diabetic group (P < 0.05; Figure 2a-c) . However, the PPAR-c inhibitor, BADGE, antagonized the protective effects of vitamin D 3 (P < 0.05; Figure 2a -c). Spermatogenesis of testis is an important index to evaluate the gonad function of male rats. We observed that compared with group NC, the sperm count decreased significantly in group DM (P < 0.05; Figure 2a,b) , and the malformation rate increased significantly (P < 0.05; Figure 2c ). However, after treatment with vitamin D 3 , the total counts and activity of sperm increased and the malformation rate decreased in group LVD and HVD (P < 0.05; Figure 2a-c) . However, the PPAR-c inhibitor, BADGE, can antagonize the protective effects after treatment with vitamin D 3 , reduce the total sperm count and viability, and increase the malformation rate (P < 0.05; Figure 2a-c) .
Pathological lesions in diabetic rat testes were alleviated by vitamin D 3 treatment Hematoxylin-eosin staining showed that the spermatogenic and Leydig cells were arranged loosely, and the seminiferous tubules were degenerating in the diabetic group, in comparison with their status in the NC group. The loose arrangement of the testicular germ cells and the degree of degeneration of the seminiferous tubules were ameliorated in the LDV and HDV groups, but exacerbated in the BADGE group (Figure 3a) . Our transmission electron microscopy results showed that the spermatogonia in the diabetic group were sparser with a greater extent of nuclear condensation and fragmentation than in the NC group. In addition, the mitochondria and endoplasmic reticulum were swollen in the diabetic group compared with the NC group. Consistent with hematoxylin-eosin staining, the LVD and HVD groups were lighter than the diabetic group, and the BADGE group was the heaviest (Figure 3b) .
Expression of TGF-b1 and the degree of fibrosis were decreased in diabetic rat testes after treatment with vitamin D 3 Tissue fibrosis is known to lead to testicular dysfunction. To determine the degree of fibrosis in the testicular tissues of the rats, we carried out Masson's trichrome staining. The staining showed significantly more fibrosis in the diabetic group than in the NC group. The degree of fibrosis was significantly decreased after treatment with vitamin D 3 , but the greatest degree of fibrosis was observed in the BADGE group (Figure 3c) . Furthermore, TGF-b1, a major driver of fibrosis, was significantly increased at the messenger RNA (mRNA) and protein levels in the diabetic and BADGE groups compared with the NC group. The TGF-b1 levels were significantly lower in the LVD and HVD groups than in the diabetic group (all P < 0.05; Figures 4c,d,g and 5c,f) .
NF-jB expression and apoptosis were decreased in diabetic rat testes after vitamin D 3 treatment
Apoptosis is a major cause of testicular dysfunction, so we investigated if apoptosis was increased, using terminal deoxynucleotidyl transferase dUTP nick-end labeling, in diabetic rats. We found that the degree of apoptosis in the testicular tissues of diabetic rats was higher than in the control group. The degree of apoptosis decreased after treatment with vitamin D 3 ( Figure 3c ). Previous studies showed that the NF-jB signaling pathway is a major regulator of apoptosis 17 . Western blotting showed that the levels of NF-jB and Bax were significantly increased in the diabetic group compared with in the NC group. After treatment with vitamin D 3 , the levels of NF-jB and Bax were significantly lower than in the diabetic group. The levels of NF-jB and Bax were highest in the BADGE group (all P < 0.05; Figure 6a ,e,f). In contrast, we found that the levels of phospho-NF-jB, IjBa, and B-cell lymphoma 2 were significantly lower in the diabetic and BADGE groups than in the NC group. Compared with their levels in the diabetic group, the levels of these proteins were significantly lower after treatment with vitamin D 3 (all P < 0.05; Figure 6b -e,g,h).
Levels of VDR and PPAR-c were increased in diabetic rat testes after treatment with vitamin D 3
Peroxisome proliferator-activated receptor gamma is upstream of TGF-b1 and NF-jB, and vitamin D 3 can regulate the expression of PPAR-c. Vitamin D 3 signaling through VDR can promote PPAR-c expression. Therefore, we examined the expression of VDR and PPAR-c in the testes of the experimental animals. The quantitative reverse transcription polymerase chain reaction, western blotting, and immunofluorescence results showed that the relative mRNA and protein levels of VDR and PPAR-c were significantly lower in the diabetic group than in the NC group. The relative mRNA and protein levels of VDR and PPAR-c were significantly increased in the LVD and HVD groups compared with in the diabetic group. The BADGE group had the lowest relative mRNA and protein 
Vitamin D 3 has no significant effect on pituitary function in diabetic rats
The present results suggest that the serum levels of LH and FSH did not significantly change after vitamin D 3 treatment. However, changes in hormone levels can be a function of morphological changes. Therefore, we examined if the pituitary tissues were altered in morphology, structure or molecular composition to determine if any changes upstream of hormone production had occurred. Hematoxylin-eosin staining showed no significant difference in the morphology of the pituitary cells among the groups. Transmission electron microscopy analysis showed no significant differences in the number and size of the gonadotroph endocrine granules among the groups. Immunohistochemistry showed that VDR protein expression in the pituitary cells did not vary statistically among the groups. The pituitary gonadotropic cells were scattered along the far side of the pituitary gland, and the expression of FSH and LH was not statistically different among the groups (all P > 0.05; Figure 7 ).
DISCUSSION
The present study focused on the mechanism of vitamin D 3 -mediated protection of gonadal function and its site of action in diabetic rats. We found that vitamin D 3 protects gonad function by acting on the testes, not the pituitary, through PPAR-c/ TGF-b1/NF-jB signaling. At the same time, the protective effect of vitamin D 3 on testicular function in diabetic rats was not related to the dose of vitamin D 3 .
Vitamin D is a multifunctional signaling molecule with a well-established role in the regulation of calcium homeostasis and bone health. With increasing research, the role of vitamin D in the regulation of non-calcium/phosphorus pathways in diabetes mellitus and its complications has been gradually recognized 18 . Our previous study showed that treatment with vitamin D 3 can improve testicular function in diabetic rats, which led us to investigate the mechanism of male hypogonadism caused by vitamin D 3 deficiency in diabetes mellitus.
Testicular tissue fibrosis and apoptosis cause testicular damage and impair function 19, 20 , so we analyzed the degrees of fibrosis and apoptosis in the testicular tissues of diabetic rats. We found that vitamin D 3 reduced fibrosis and apoptosis in the testes of diabetic rats. Previous studies reported that activation of the TGF-b pathway was associated with fibrosis in the testes 21, 22 . The present data suggest that TGF-b1 mRNA and protein levels were increased in diabetic rat testes, but decreased after treatment with vitamin D 3 . Therefore, we conclude that vitamin D 3 can improve testicular function through modulation of the TGF-b1 signaling pathway.
Activation of the NF-jB/Bax pathway can cause apoptosis 17, 23 . The inactive form of NF-jB resides in the cytoplasm and associates or links with its natural biological inhibitor, IjB 24 . NF-jB can enter the nucleus and cause apoptosis after it dissociates from inhibitor of NF-jB. Consistent with previous studies, the present data showed that NF-jB p65, phosphoIjBa and Bax levels were significantly higher in diabetic rats than in the LVD and HVD groups.
Expression of PPAR-c, a member of the nuclear receptor superfamily, can improve testicular function and regulate the expression of TGF-b1 and NF-jB 12, 25 . Both PPAR-c and VDR can interact with the retinoid X receptor 7, 12 . Given that vitamin D 3 can also regulate the expression of PPAR-c 13 , we assessed the expression of PPAR-c in our model. We found that the decrease in PPAR-c levels in the testes of diabetic rats was antagonized by vitamin D 3 . Thus, we conclude that vitamin D 3 can improve testicular function by activating PPAR-c. To validate this conclusion, we utilized the PPAR-c inhibitor, BADGE 26, 27 , and found that testicular function was decreased, and fibrosis and apoptosis were increased in the BADGE group. We identified a possible mechanism through which PPAR-c inhibits fibrosis and apoptosis in the testes.
VDR mRNA and protein are expressed in the human pituitary gland, suggesting a particular role for vitamin D 3 in the central reproductive organs 28 . We hypothesized that vitamin D 3 might improve gonadal function by improving pituitary function in diabetic rats. We found that the serum FSH and LH concentrations were similar in each group, as was the immunohistochemical staining for VDR, FSH and LH. Thus, in our experiments, vitamin D 3 had no apparent effect on pituitary function in diabetic rats. The present experimental results are consistent with some previous studies 29, 30 . Our results could be due to the difficulty of exogenous vitamin D 3 passing through the blood-brain barrier or because vitamin D receptor is only expressed in other cells in the pituitary gland, in addition to the gonadotroph. Further study is required to resolve the effects of vitamin D 3 on the individual types of pituitary cells.
In summary, the present findings showed that vitamin D 3 can alleviate fibrosis and apoptosis in the testicular tissue of diabetic rats, likely through PPAR-c/TGF-b1/NF-jB signaling. However, over the period of the study, diabetes did not affect the pituitary gonadotroph in rats. These findings provide new insights into the role of vitamin D 3 in diabetes, and indicate that vitamin D 3 supplementation could be a new adjunctive therapy for testicular dysfunction in people with diabetes. 
